AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT03754738 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Balloon guide catheter
Description: Use a balloon guide catheter in the mechanical thrombectomy
Study NCT03754738 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Non-balloon guide catheter
Description: Use a non-balloon guide catheter in the mechanical thrombectomy
Study NCT03031028 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: ketogenic diet
Description: Ketogenic Diet is a high fat, low carbohydrate diet.
Study NCT04757558 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: C-MAC video-stylet
Description: Patients will be randomly assigned two group 40 patients each, C-MAC-VS group (VS group) (Karl Storz GmbHand Co.KG, Germany), and control group (C group). This will be done using a closed envelope technique using a computer-generated block randomization method.
Study NCT04757558 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Macintosh laryngoscope
Description: Patients will be randomly assigned two group 40 patients each, C-MAC-VS group (VS group) (Karl Storz GmbHand Co.KG, Germany), and control group (C group). This will be done using a closed envelope technique using a computer-generated block randomization method.
Study NCT06143761 — intervention group
Intervention type: DRUG
Intervention: PD-1 inhibitor+carboplatin+albumin-bound paclitaxel
Description: A comparative evaluation of patient prognosis between those who received neoadjuvant chemoimmunotherapy-surgery treatment and those who underwent surgery alone.
Study NCT03946657 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Inhalational anesthetic
Description: Oxygen/air (fraction of inspired oxygen (FiO2) of 0.40), inspiratory fresh gas flow of 2 L/min), sevoflurane (1 minimum alveolar concentration \[MAC\]) and remifentanil IV infusion (0.1-0.25 mcg/kg of LBW/min) were used.Neuromuscular blockade was performed during the operation by rocuronium infusion (0.3-0.7 mg/kg of LBW/h), ensuring that PTC was zero.
Study NCT03946657 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Intravenous anesthetic
Description: Propofol infusion (4-8 mg/kg of total body weight/h), oxygen/air (FiO2 of 0.40; inspiratory fresh gas flow of 2 L/min) and remifentanil IV infusion (0.1-0.25 μg/kg of LBW/min) were used.Neuromuscular blockade was performed during the operation by rocuronium infusion (0.3-0.7 mg/kg of LBW/h), ensuring that PTC was zero.
Study NCT03174964 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IVIg
Description: Patients will take a dose of 400mg/kg of IVIg 2 days before ET.
Study NCT03199716 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Parent mentors
Description: Parent mentors are to meet up with their assigned intervention group 4 times in 1 year and call the families monthly to document any diabetic complications
Study NCT04511130 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MT-401
Description: MT-401 (zedenoleucel) is an allogeneic multi-tumor-associated antigen (MultiTAA)-specific T cell product manufactured under Good Manufacturing Practice (GMP) using donor-derived T cells obtained from apheresis.
Study NCT00005305 — intervention group
Intervention type: OTHER
Intervention: No interventions - observational study
Study NCT02748239 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: MEDIAS 2 CT
Description: The MEDIAS 2 CT is a education program for the initiation of a conventional insulin therapy in type 2 diabetic patients. The program consists of 6 lessons and is conducted in group settings (4-8 participants).
Study NCT02748239 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Current CT program
Description: The Current CT program is currently used for the initiation of conventional insulin therapy in type 2 diabetic patients. The program consists of 6 lessons and is conducted in group settings (4-8 participants).
Study NCT02687113 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: CT/US fusion
Description: Fusion of pre-RFA cross-sectional imaging (CT or MRI) and real-time USG using registration function of USG device.
Study NCT00565682 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: etoricoxib 120 mg
Description: etoricoxib 120 mg, tablet, orally, OD
Study NCT03466840 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: The coronally advanced lingual flap
Description: : A full-thickness crestal incision is performed from the distal surface of the more distal tooth to retromolar pad and finishing with releasing incision. On the lingual side, a full-thickness muco-periosteal flap was elevated until reaching mylohyoid line. Then using a blunt instrument, it was localized a connective tissue band continuing with the epimysium of the mylohyoid muscle. It is inserted into the inner part of the lingual flap about 5mm from the crest in an apical direction. The blunt instrument is inserted below the connective band, and with gentle traction in the coronal direction, this muscular insertion was detached from the lingual flap. Using a periodontal probe, the amount of advancement is measured.
Study NCT03466840 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Modified periosteal releasing Incision
Description: A full-thickness muco-periosteal flap is reflected on the buccal side. Near the base of muco-periosteal flap, the periosteum is incised less than 0.5mm in depth, creating two segments, coronal segment and apical segment, of the periosteal flap. The flap is pulled with a pair of periodontal forceps laterally. Subsequently, the lateral stretching of the coronal segment of the flap is performed by applying pressure using the blunt face of scalpel blade, or a blunt instrument, with sweeping motion. This motion helps stretching the flap over the submucosa, thereby permitting the flap to be mobile.Using a periodontal probe the amount of advancement is measured.
Study NCT01953510 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: PCV10
Description: PCV10 includes serotypes 1, 4, 5, 6B, 7F, 9V, 14, 18C, 19F and 23F and protein D is the main carrier protein
Study NCT01953510 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: PCV10
Description: PCV10 includes serotypes 1, 4, 5, 6B, 7F, 9V, 14, 18C, 19F and 23F and protein D is the main carrier protein
Study NCT01953510 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: PCV13
Description: PCV13 includes serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F, individually linked to non-toxic diphtheria CRM197 carrier protein
Study NCT02093377 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Adaptive servo-ventilation
Description: Adaptive servo-ventilation (ASV, most recent technology of AutoSetCS device, ResMed, Sydney, Australia)
Study NCT02818751 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Escitalopram
Description: Patients being randomized to receive escitalopram.
Study NCT02818751 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Patients being randomized to receive placebo.
Study NCT00684437 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Focus Group
Description: Focus group discussion and evaluation of various smoking risk informational messages. The focus group session should last about 1 hour and 30 minutes.
Study NCT00684437 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Questionnaire
Description: Questionnaires taking 15-30 minutes to complete.
Study NCT03069131 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rifaximin
Description: twice daily administration of 1 tablet containing 550 mg of active rifaximin
Study NCT03069131 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: twice daily administration of 1 rifaximin placebo tablet
Study NCT04197908 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: EUS-guided gallbladder drainage (EGBD)
Description: As listed in the arms description
Study NCT02064153 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Cool dialysate
Description: Each recruited patient undergoes a cool dialysate session ( 35.5ºC) and a warm dialysate session (37ºC). The sessions are minimum a week apart to remove the carryover effect.
Study NCT02064153 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Warm dialysate
Description: All recruited patients will undergo two study sessions - Cool dialysis (35.5ºC) and Warm dialysis (37ºC)
Study NCT02337322 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dolutegravir
Study NCT02337322 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Darunavir/r
Study NCT01200186 — intervention group
Intervention type: DRUG
Intervention: EV/DNG (Qlaira, BAY86-5027)
Description: At the discretion of the attending physician
Study NCT01200186 — intervention group
Intervention type: DRUG
Intervention: Progestin Only Pills
Description: At the discretion of the attending physician
Study NCT03826030 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham
Description: Sham group only receives 30 seconds of stimulation at 2mA in the beginning to create a sensory perception to the scalp in order to blind the subject.
Study NCT03826030 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Low dose tDCS
Description: The low dose tDCS group receives direct current stimulation at 2 mA for 30 minutes per session
Study NCT03826030 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: High dose tDCS
Description: The high dose tDCS group receives direct current stimulation at 4 mA for 30 minutes per session
Study NCT03826030 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: mCIMT
Description: All three tDCS groups receive constraint-induced movement therapy as the adjunctive behavioral therapy for 2 hours per session
Study NCT03826030 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: mCIMT
Description: All three tDCS groups receive constraint-induced movement therapy as the adjunctive behavioral therapy for 2 hours per session
Study NCT06693024 — intervention group
Intervention type: DRUG
Intervention: neratinib
Description: neratinib 240mg qd for 1 year
Study NCT03967522 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cabozantinib
Description: All participants will be treated by 60 mg of cabozantinib once daily. Temporary or permanent discontinuation and/or dose reduction of cabozantinib therapy may be required for the management of some adverse reactions. When dose reduction is necessary, it is recommended to reduce to 40 mg daily, and then to 20 mg daily.
Study NCT06698185 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Materna Prep Device
Description: Materna Prep Device
Study NCT06698185 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham Control
Description: Sham Control
Study NCT04060784 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Immediate implant placement and provisionalization
Description: Failing tooth will be extracted and immediate placed endosseous implant
Study NCT03923673 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Pericardiotomy
Description: The minimally invasive procedure that creates a small opening in the sac that surrounds the heart.
Study NCT01049750 — intervention group
Intervention type: OTHER
Intervention: type 2 diabetic patients
Description: males; type 2 diabetic patients
Study NCT03749382 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: AprilAge- facial morphing appearance based intervention for smoking
Description: Appearance-based intervention: The intervention is a software that ages an individual's face with and without the effects of smoking. Participants have their photo taken on a laptop webcam, they are then asked to report their age and ethnicity in order to calibrate the software, the participants picture is then matched to a stock image. The participants will see two images on the screen, on the left is there face aged without the effects of smoking and one the right aged with the effects of smoking. Participants will be led through a series of morphing sequences (1-5). In-between each of the morphing sequences (Morph1 to Morph5) the participant will be asked to comment on the differences they can see between the two images.~General stop smoking intervention: The General stop smoking intervention comes in the form of a NHS stop smoking information leaflet. The participants will be given the leaflet on a laptop screen and asked to read through the whole document.
Study NCT00081471 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: darbepoetin alfa
Description: 0.45 micrograms/kg sc (starting dose) weekly
Study NCT03755154 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: S65487- initial scheme
Description: S65487 is administered as single agent via i.v. infusion once a week on a 3-week cycle.
Study NCT03755154 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: S65487 - alternative scheme
Description: S65487 is administered in 3 to 5 i.v. infusions the first week of each cycle then once a week on the rest of the 3-week cycle.
Study NCT04588077 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Heplisav-B Injectable Product, 2-dose regimen
Description: Investigators will randomly assign patients into a 2-dose regimen.
Study NCT00081471 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: methoxy polyethylene glycol-epoetin beta [Mircera]
Description: 0.6 micrograms/kg sc (starting dose) once every 2 weeks
Study NCT01241136 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: open wide-excision pilonidal cystectomy
Description: traditional open wide-excisional pilonidal cystectomy
Study NCT01241136 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: minimal invasive pilonidal cystotomy
Description: unroofing the cyst cavity and curettage the cyst
Study NCT04588077 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Heplisav-B Injectable Product, 3-dose regimen
Description: Investigators will randomly assign patients into a 3-dose regimen.
Study NCT03606135 — intervention group
Intervention type: OTHER
Intervention: The Pneumonia Group
Study NCT03606135 — intervention group
Intervention type: OTHER
Intervention: The Control Group
Study NCT05299489 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Direct restoration
Description: Local anesthesia was achieved and the tooth were isolated using a rubber dam. Then, the entire caries and hypomineralized enamel were removed using diamond burs and removal the affected dentine caries by slow speed handpiece, the final preparation must be on intact enamel. The molars were wiped using 5.25% sodium hypochlorite followed by rinsing with water, etching using 37% phosphoric acid The surface of the restoration, bonding, applying composite and assessment of occlusion.
Study NCT05299489 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Indirect restoration
Description: Local anesthesia was achieved and the tooth were isolated using a rubber dam. Then, the entire caries and hypomineralized enamel were removed using diamond burs and removal the affected dentine caries by slow speed handpiece, the final preparation must be on intact enamel. Preparation walls were vertical according to the longitudinal axis of the tooth and the occlusal depth 2 mm. The impressions were taken for both jaws and the bite were recorded for the using red wax. The cavity in example were painted with insulating material. Indirect composite resin were applied, finishined and polished.~Cementation:~Tooth surface: The molars were wiped using 5.25% sodium hypochlorite followed by rinsing with water, etching using 37% phosphoric acid The surface of the restoration: application of silane coupling agent to enhance the formation of resin tags.~Dual cure resin cement was used for final cementation followed by an assessment of occlusion.
Study NCT03141801 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: DELFI PTS Personalized Tourniquet System for Blood Flow Restriction Training
Description: cuff is inflated to 80% of an individuals limb occlusion pressure
Study NCT03141801 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Eccentric Exercise with BLAST Leg Press System
Description: 4 sets of 10 repetitions of an eccentric leg press exercise performed at 70% of the 1 repetition maximum
Study NCT03141801 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Eccentric Exercise with BLAST Leg Press System
Description: 4 sets of 10 repetitions of an eccentric leg press exercise performed at 70% of the 1 repetition maximum
Study NCT03141801 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Concentric Exercise with BLAST Leg Press System
Description: 4 sets of 10 repetitions of an concentric leg press exercise performed at 70% of the 1 repetition maximum
Study NCT03141801 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Concentric Exercise with BLAST Leg Press System
Description: 4 sets of 10 repetitions of an concentric leg press exercise performed at 70% of the 1 repetition maximum
Study NCT03028025 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: StatSeal
Description: Patients randomly assigned to the experimental group will have a Statseal Advance (SSA) disc applied after withdrawing the radial sheath 2-4 cm. A Tegaderm dressing will be applied to secure the disc position. The TR band will be applied over the SSA disc with the center of the balloon (the green dot) over the center of the SSA disc. The TR band will be inflated with 8cc of air (which is typically occlusive pressure), and the sheath removed. No deflation will occur immediately. After 20 minutes of pressure, 3 cc of air will be removed from the TR band. After an additional 20 minutes (40 minutes after procedure), the TR band will be completely deflated, and the TR band left in place. After an additional 20 minutes (60 minutes after procedure) the TR band will be removed.
Study NCT03028025 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: TR Band
Description: Patients randomly assigned to the control group will have a TR band applied over the arteriotomy site and inflated with 15-18ml of air. After aspirating and clearing the contents of the sheath, the radial sheath will be removed. The TR band will be deflated until bleeding occurs, and 2 ml of air will be reintroduced to provide hemostasis. Patent hemostasis will be documented with plethysmography and oximetry as described below within 5 minutes after band application and removal, and within 30 min of discharge or after 24 hours. The TR band will be left inflated and in place for 2 hours following the procedure for all patients (regardless of diagnostic or PCI procedure), after which deflation attempts will commence.
Study NCT02452970 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RRx-001
Description: RRx-001 (10 mg/m2) intravenously twice weekly for up to six weeks followed by retreatment with Gemcitabine 1000 mg/m2 and Cisplatin 30 mg/m2 on Days 1 and 8 of a 21 Day Cycle until tumor progression
Study NCT02452970 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine and cisplatin
Description: RRx-001 (20 mg) intravenously weekly for up to six weeks followed by retreatment with Gemcitabine 1000 mg/m2 and Cisplatin 25 mg/m2 on Days 1 and 8 of a 21 Day Cycle until tumor progression
Study NCT01270893 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nilotinib
Description: 400 mg by mouth twice a day for 7 days. Patients on Arm 2 will continue to receive Nilotinib until they have disease progression or are resectable.
Study NCT03753568 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Electronic medicine reminder system
Description: Electronic surveillance device is attached to the participants push through pill sheet and the smart phone application reminds the participants to take their medicine if they are about to take their daily dosage.
Study NCT03742492 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Meal containing canned tuna + fish oil (5 g EPA + DHA)
Description: Meal containing canned tuna + fish oil (5 g EPA + DHA)
Study NCT03742492 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Meal containing canned tuna + soybean oil
Description: Meal containing canned tuna + soybean oil
Study NCT03472482 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: non-invasive retinal imaging
Study NCT01974674 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Allogeneic transplantation of intrahepatic islet
Study NCT03574467 — intervention group
Intervention type: BEHAVIORAL
Intervention: Bobath Neurodevelopmental Treatment Approach
Description: The Bobath Neurodevelopmental Treatment (NDT) rehabilitation approach is effective in increasing the functional capacity and acquiring independence in patients with stroke and brain tumor.
Study NCT00962065 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LX4211 Low Dose
Description: A low dose of LX4211; daily oral intake for 28 days
Study NCT00962065 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LX4211 High Dose
Description: A high dose of LX4211; daily oral intake for 28 days
Study NCT00962065 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching placebo dosing with daily oral intake for 28 days
Study NCT00772512 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-04802540
Description: 5 mg capsule, single dose
Study NCT00772512 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-04802540
Description: 15 mg capsule, single dose
Study NCT00772512 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo capsule, single dose
Study NCT01340287 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: 1- plain low-fat dairy fermented product (drinkable) enriched with plant sterols-esters (1,6g /day equivalent as free sterols).
Description: 1 = Intervention 1 (1 test product/day)